Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Masaru Matsuda currently holds 150,641 shares of HALOZYME THERAPEUTICS, INC. (HALO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Masaru Matsuda has been a net seller of HALO stock. They have purchased $0 and sold $1.2M worth of shares.
Masaru Matsuda's most recent insider trade was on Dec 1, 2025, when they sold 1,657 shares at $30.23 per share.
Masaru Matsuda serves as Executive at HALOZYME THERAPEUTICS, INC. (HALO). They have executed 43 insider transactions totaling $1.2M over their tenure at the company.
Masaru Matsuda holds the position of Executive at HALOZYME THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Masaru Matsuda has shown a selling trading pattern, with $0 in total purchases and $1.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Masaru Matsuda was on Sep 4, 2025, when they sold $583.9K worth of ARQT shares. This transaction involved 36,130 shares at $16.16 per share.
Masaru Matsuda currently owns 150,641 shares of HALOZYME THERAPEUTICS, INC. (HALO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Masaru Matsuda's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Masaru Matsuda has 43 Form 4 filings on record as an insider at HALOZYME THERAPEUTICS, INC..
Set alerts for Masaru Matsuda and 40,000+ other insiders.